Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.
Dr. Karen Gripp, Erin Wadman & Carolina Alves talk about the delineation of a new syndrome associated with prenatal fentanyl exposure based on the study’s findings as recently published in Genetics in Medicine Online. This Webinar was conducted on Dec 4, 2023:
En conmemoración del Día Mundial de las Personas sin Diagnóstico, el 29 de abril, la RELAGH y el FDNA hicieron un seminario web sobre la aplicación de la inteligencia artificial en enfermedades no diagnosticadas. En el evento participaron: José Elias García Ortiz, doctor en genética humana de México, quien habló sobre las enfermedades no diagnosticadas […]
The FDNA team is excited to be back at the European Human Genetics Conference #eshg2023, June 10-13 in Glasgow-UK and tell you more about Face2Gene’s Pediatrician View and the new options for case analysis (using the GestaltMatcher technology). To learn more, swing by our booth (#156), or contact us and schedule a meeting with a […]
FDNA team is gearing up for conferences and meetings in 2023, and we are excited to share with you new developments and updates. Check out below the events we will be attending, and if you have any questions contact us to schedule a meeting. 14th International Congress of Human Genetics – ICHG 2023 FEBRUARY 22-26 […]
The FDNA team is excited to be at the American Society of Human Genetics (ASHG) Annual Meeting, October 25-29 in Los Angeles. ASHG is the world’s largest gathering of human genetics professionals, bringing in members and scientists from all over the world to share their research. You can see our top picks of what to […]
Rare diseases affect roughly 30 million Americans, yet only 5 percent of the estimated 7,000 known rare diseases have cures or treatments approved by the FDA. Each February, clinical, tech, and advocacy communities around the world pause to reflect on this fact and take time to recognize the strides we’ve made and what is to […]
San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Annual Meeting, October 16-20 in San Diego and tell you more about how Face2Gene facilitates the sharing of phenotypic information with labs for improved NGS analysis. To learn more, attend our exhibitor education event, swing […]
FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The article below is based on the information he presented at the conference. By now, AI is so commonplace it’s almost embarrassing if a tech company doesn’t use it. But as much as the sci-fi world […]
A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s ESHG as a part of FDNA’s corporate satellite talk and various scientific posters. Karin Weiss (Rambam Health Care Campus, Haifa, Israel) presented her further work on Sifrim Hitz Weiss Syndrome (SIHIWES), a recently described form […]